Literature DB >> 9311129

Identification of the Treponema pallidum subsp. pallidum glycerophosphodiester phosphodiesterase homologue.

C E Stebeck1, J M Shaffer, T W Arroll, S A Lukehart, W C Van Voorhis.   

Abstract

To identify potential opsonic targets of Treponema pallidum subsp. pallidum, a treponemal genomic expression library was constructed and differentially screened with opsonic and non-opsonic T. pallidum antisera. This method identified an immunoreactive clone containing an open reading frame encoding a 356 residue protein. Nucleotide sequence analysis demonstrated the translated protein to be a homologue of glycerophosphodiester phosphodiesterase, a glycerol metabolizing enzyme previously identified in Haemophilus influenzae, Escherichia coli, Bacillus subtilis and Borrelia hermsii. Sequence alignment analyses revealed the T. pallidum and H. influenzae enzymes share a high degree of amino acid sequence similarity (72%), suggesting that in T. pallidum this molecule may be surface exposed and involved in IgD binding as is the case with its counterpart in H. influenzae.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9311129     DOI: 10.1111/j.1574-6968.1997.tb12660.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  13 in total

1.  Physicochemical evidence that Treponema pallidum TroA is a zinc-containing metalloprotein that lacks porin-like structure.

Authors:  R K Deka; Y H Lee; K E Hagman; D Shevchenko; C A Lingwood; C A Hasemann; M V Norgard; J D Radolf
Journal:  J Bacteriol       Date:  1999-07       Impact factor: 3.490

2.  Membrane topology and cellular location of the Treponema pallidum glycerophosphodiester phosphodiesterase (GlpQ) ortholog.

Authors:  D V Shevchenko; T J Sellati; D L Cox; O V Shevchenko; E J Robinson; J D Radolf
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

3.  Multiple alleles of Treponema pallidum repeat gene D in Treponema pallidum isolates.

Authors:  A Centurion-Lara; E S Sun; L K Barrett; C Castro; S A Lukehart; W C Van Voorhis
Journal:  J Bacteriol       Date:  2000-04       Impact factor: 3.490

4.  Sequence conservation of glycerophosphodiester phosphodiesterase among Treponema pallidum strains.

Authors:  C E Cameron; C Castro; S A Lukehart; W C Van Voorhis
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

5.  The Treponema denticola major sheath protein is predominantly periplasmic and has only limited surface exposure.

Authors:  M J Caimano; K W Bourell; T D Bannister; D L Cox; J D Radolf
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

6.  Serodiagnosis of Louse-Borne relapsing fever with glycerophosphodiester phosphodiesterase (GlpQ) from Borrelia recurrentis.

Authors:  S F Porcella; S J Raffel; M E Schrumpf; M E Schriefer; D T Dennis; T G Schwan
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

7.  Cloning and characterization of a human GDPD domain-containing protein GDPD5.

Authors:  Qingyu Lang; Haoxing Zhang; Jie Li; Hongkun Yin; Yifeng Zhang; Wenwen Tang; Bo Wan; Long Yu
Journal:  Mol Biol Rep       Date:  2007-06-20       Impact factor: 2.316

8.  Function and protective capacity of Treponema pallidum subsp. pallidum glycerophosphodiester phosphodiesterase.

Authors:  C E Cameron; C Castro; S A Lukehart; W C Van Voorhis
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

9.  Serodiagnosis of syphilis: antibodies to recombinant Tp0453, Tp92, and Gpd proteins are sensitive and specific indicators of infection by Treponema pallidum.

Authors:  Wesley C Van Voorhis; Lynn K Barrett; Sheila A Lukehart; Bruno Schmidt; Martin Schriefer; Caroline E Cameron
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

10.  A trigger enzyme in Mycoplasma pneumoniae: impact of the glycerophosphodiesterase GlpQ on virulence and gene expression.

Authors:  Sebastian R Schmidl; Andreas Otto; Maria Lluch-Senar; Jaume Piñol; Julia Busse; Dörte Becher; Jörg Stülke
Journal:  PLoS Pathog       Date:  2011-09-22       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.